CoChat

Prevention by Protein Kinase C Inhibitors of Glucose-Induced Insulin-Receptor Tyrosine Kinase Resistance in Rat Fat Cells

Müller, H K, Kellerer, M, Ermel, B, Mühlhöfer, A, Obermaier-Kusser, B, Vogt, B, Häring, H U · 1991 · Diabetes
Cited by 101

The DOI matches its Crossref record.

Abstract

Hyperglycemia causes insulin-receptor kinase (IRK) resistance in fat cells. We characterized the mechanism of IRK inhibition and studied whether it is the consequence of a glucose-induced stimulation of protein kinase C (PKC). Fat cells were incubated for 1 or 12 h in culture medium containing either a low- (5-mM) or high- (25-mM) glucose concentration. IRK was isolated, insulin binding was determined, and autophosphorylation was studied in vitro with [γ-32P]ATP or was determined by Western blotting with anti-phosphotyrosine antibodies. Substrate phosphorylation was investigated with the artificial substrate poly(Glu80-Tyr20). Partially purified insulin receptor from rat fat cells, which were cultured under high-glucose conditions for 1 or 12 h, showed no alteration of insulin binding but a reduced insulin effecton autophosphorylation (30 ± 7% of control) and poly(Glu80-Tyr20) phosphorylation (55.5 ± 9% of control). Lineweaver-Burk plots of the enzyme kinetics revealed, beside a reduced Vmax, and increased KM (from 30 μM to 80 μM) for ATP of IRK from high-glucose–treated cells. Because a similar inhibition pattern was earlier found for IRK from fat cells afteracute phorbol ester stimulation, we investigated whether activation of PKC might be the cause of the reduced IRK activity. We isolated PKC from the cytosol and the membrane fraction of high- and low-glucose fat cells and determined the diacylglycerol- and phospholipid-stimulated PKC activity toward the substrate histone. There was no significant change of cytosolic PKC; however, membrane-associated PKC activity was increased in high-glucose–treated cells. To evaluate whether the activation of PKC causes the inhibitors (H 7, staurosrine, and polymyxin B) and tested whether the effect of hyperglycemia was stillpresent when fat cells were pretreated with phorbolester (tetradecanoylphorbol acetate) for 24 h. Indeed, H 7, staurosporine, and polymyxin B blocked the inhibitory effect of hyperglycemia on IRK. Furthermore, in cells treated for 24 h with tetradecanoylphorhol acetate, no inhibitory effect of hyperglycemia was observed. This and the effect of the PKC inhibitors are consistent with a causal relationship between IRK inhibition and PKC activation

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.40.11.1440

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 101

Metadata

Authors
Müller, H. K., Kellerer, M., Ermel, B., Mühlhöfer, A., Obermaier-Kusser, B., Vogt, B., & Häring, H. U.
Venue
Diabetes
Published
1991-11-01
Volume
40
Issue
11
Pages
1440-1448
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2093487081
Cited by
101
References
0
FWCI
1.14
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention by Protein Kinase C Inhibitors of Glucose-Induced Insulin-Receptor Tyrosine Kinase Resistance in Rat Fat Cells. https://app.cochat.ai/papers/10.2337/diab.40.11.1440
The paper
Müller, H. K., Kellerer, M., Ermel, B., Mühlhöfer, A., Obermaier-Kusser, B., Vogt, B., & Häring, H. U. (1991). Prevention by Protein Kinase C Inhibitors of Glucose-Induced Insulin-Receptor Tyrosine Kinase Resistance in Rat Fat Cells. Diabetes. https://doi.org/10.2337/diab.40.11.1440

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.